We found that the majority of CD45+Col-I+ cells expressed CXCR4 (Fig 2C), and all measured counts of differentiated fibrocyte populations CD45+Col-I+ αSMA+cells (Fig 2D) were higher among patients with BPD compared to normal control. This evidence concerns the gene CXCR4 and bronchopulmonary dysplasia.